UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of prostate-specific antigen relapse in prostate cancer: A European consensus

International journal of clinical practice (Esher), 2004-04, Vol.58 (4), p.382-390

2004

Volltextzugriff (PDF)

The global state of prostate cancer: new diagnostic tools, minimal requirements for diagnosis and staging, and guidelines in the second millennium

BJU international, 2004-12, Vol.94 (s3), p.3-4

Teillac, P.

2004

Volltextzugriff (PDF)

The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography‐guided biopsy of the prostate: a prospective randomized placebo‐controlled study

BJU international, 1999-06, Vol.83 (9), p.1007-1009

1999

Volltextzugriff (PDF)

Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract

Oncogene, 2006-03, Vol.25 (14), p.2113-2118

2006

Volltextzugriff (PDF)

Evaluation of the Transurethral Ethanol Ablation of the Prostate (TEAP) for Symptomatic Benign Prostatic Hyperplasia (BPH): A European Multi-Center Evaluation

European urology, 2004-10, Vol.46 (4), p.496-502

2004

Volltextzugriff (PDF)

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer

British journal of cancer, 2005-01, Vol.92 (2), p.236-240

2005

Volltextzugriff (PDF)

Results of an Epidemiological Survey Using a Modified American Urological Association Symptom Index for Benign Prostatic Hyperplasia in France

The Journal of urology, 1994-05, Vol.151 (5), p.1266-1270

1994

Volltextzugriff (PDF)

Relief of BPO or Improvement in Quality of Life?

European urology, 1998-01, Vol.34 (Suppl 2), p.3-9

Teillac, Pierre

1998

Volltextzugriff (PDF)

Telomerase activity as a potential marker in preneoplastic bladder lesions

BJU international, 2000-03, Vol.85 (4), p.526-531

2000

Volltextzugriff (PDF)

The clinical implications of the Prostate Cancer Prevention Trial

BJU international, 2003-11, Vol.92 (7), p.667-671

2003

Volltextzugriff (PDF)

Is there a place for neoadjuvant hormonal therapy before radical prostatectomy or radiation therapy in the management of prostate cancer?

Prostate cancer and prostatic diseases, 1999-11, Vol.2 (S2), p.S8-S11

Teillac, P

1999

Volltextzugriff (PDF)

Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial

BJU international, 2012-11, Vol.110 (9), p.1262-1269

2012

Volltextzugriff (PDF)

Plasma Neuroendocrine Markers in Patients with Benign Prostatic Hyperplasia and Prostatic Carcinoma

The Journal of urology, 1996-04, Vol.155 (4), p.1340-1343

1996

Volltextzugriff (PDF)

An Original Antireflux Ureteroileal Implantation Technique: Long-Term Followup

The Journal of urology, 1987-06, Vol.137 (6), p.1156-1158

1987

Volltextzugriff (PDF)

Dépistage du cancer de la prostate : synthèse

Annales d'urologie, 2006-04, Vol.40 (2), p.106-110

2006

Volltextzugriff (PDF)

Benign prostatic hyperplasia: a progressive disease of aging men

Urology, 2003-02, Vol.61 (2), p.267-273

2003

Volltextzugriff (PDF)

Comparison of a Phytotherapeutic Agent (Permixon) with an α-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

European urology, 2002-05, Vol.41 (5), p.497-507

2002

Volltextzugriff (PDF)

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

Expert opinion on pharmacotherapy, 2004-10, Vol.5 (10), p.2171-2179

2004

Volltextzugriff (PDF)

Gene transfer to urethral strictures in rabbits: a preliminary report

BJU international, 2000-06, Vol.85 (9), p.1120-1125

2000

Volltextzugriff (PDF)

Que peut attendre aujourd'hui le clinicien du dosage du PSA?

Nuclear medicine and biology, 1994, Vol.21 (3), p.455-469

TEILLAC, P

1994

Volltextzugriff (PDF)

Evaluation of Male Sexual Function in Patients with Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Treated with a Phytotherapeutic Agent (Permixon ®), Tamsulosin or Finasteride

European urology, 2005-08, Vol.48 (2), p.269-276

2005

Volltextzugriff (PDF)

The conservative management of Corynebacterium group D2 encrusted pyelitis

BJU international, 1999-08, Vol.84 (3), p.270-275

1999

Volltextzugriff (PDF)

Immortalization of Human Adult Normal Prostatic Epithelial Cells by Liposomes Containing Large T-SV40 Gene

The Journal of urology, 1991-09, Vol.146 (3), p.881-886

1991

Volltextzugriff (PDF)

Management of Urinary Tract Infection in Elderly Men

European urology, 1991-01, Vol.19 (Suppl 1), p.23-27

Teillac, P.

1991

Volltextzugriff (PDF)

Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride

Therapie, 2002-09, Vol.57 (5), p.473

Teillac, P

2002

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(194)
Male
(140)
Science & Technology
(123)
Life Sciences & Biomedicine
(120)
Biological And Medical Sciences
(87)
Medical Sciences
(85)
Middle Aged
(82)
Female
(68)
Urology & Nephrology
(67)
Aged
(65)
Adult
(58)
Sciences Biologiques Et Medicales
(45)
Sciences Medicales
(45)
Aged, 80 And Over
(32)
Nephrology. Urinary Tract Diseases
(29)
Urinary Tract. Prostate Gland
(27)
Tumors Of The Urinary System
(23)
Animals
(22)
Child
(21)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of prostate-specific antigen relapse in prostate cancer: A European consensus

The global state of prostate cancer: new diagnostic tools, minimal requirements for diagnosis and staging, and guidelines in the second millennium

The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography‐guided biopsy of the prostate: a prospective randomized placebo‐controlled study

Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract

Evaluation of the Transurethral Ethanol Ablation of the Prostate (TEAP) for Symptomatic Benign Prostatic Hyperplasia (BPH): A European Multi-Center Evaluation

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer

Results of an Epidemiological Survey Using a Modified American Urological Association Symptom Index for Benign Prostatic Hyperplasia in France

Relief of BPO or Improvement in Quality of Life?

Telomerase activity as a potential marker in preneoplastic bladder lesions

The clinical implications of the Prostate Cancer Prevention Trial

Is there a place for neoadjuvant hormonal therapy before radical prostatectomy or radiation therapy in the management of prostate cancer?

Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial

Plasma Neuroendocrine Markers in Patients with Benign Prostatic Hyperplasia and Prostatic Carcinoma

An Original Antireflux Ureteroileal Implantation Technique: Long-Term Followup

Dépistage du cancer de la prostate : synthèse

Benign prostatic hyperplasia: a progressive disease of aging men

Comparison of a Phytotherapeutic Agent (Permixon) with an α-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

Gene transfer to urethral strictures in rabbits: a preliminary report

Que peut attendre aujourd'hui le clinicien du dosage du PSA?

Evaluation of Male Sexual Function in Patients with Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Treated with a Phytotherapeutic Agent (Permixon ®), Tamsulosin or Finasteride

The conservative management of Corynebacterium group D2 encrusted pyelitis

Immortalization of Human Adult Normal Prostatic Epithelial Cells by Liposomes Containing Large T-SV40 Gene

Management of Urinary Tract Infection in Elderly Men

Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride

Suchergebnisse filtern